Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 143

    1.

    Antiproliferative and cytostatic effects of the natural product eupatorin on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.

    Androutsopoulos V, Arroo RR, Hall JF, Surichan S, Potter GA.

    Breast Cancer Res. 2008;10(3):R39. Epub 2008 May 2.

    PMID:
    18454852
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.

    Androutsopoulos VP, Ruparelia K, Arroo RR, Tsatsakis AM, Spandidos DA.

    Toxicology. 2009 Oct 29;264(3):162-70. Epub 2009 Aug 8.

    PMID:
    19666078
    [PubMed - indexed for MEDLINE]
    3.

    Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.

    Androutsopoulos VP, Papakyriakou A, Vourloumis D, Spandidos DA.

    Bioorg Med Chem. 2011 May 1;19(9):2842-9. Epub 2011 Mar 24.

    PMID:
    21482471
    [PubMed - indexed for MEDLINE]
    4.

    Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation.

    Androutsopoulos VP, Mahale S, Arroo RR, Potter G.

    Oncol Rep. 2009 Jun;21(6):1525-8.

    PMID:
    19424633
    [PubMed - indexed for MEDLINE]
    5.

    The methoxylated flavones eupatorin and cirsiliol induce CYP1 enzyme expression in MCF7 cells.

    Androutsopoulos VP, Li N, Arroo RR.

    J Nat Prod. 2009 Aug;72(8):1390-4.

    PMID:
    19601638
    [PubMed - indexed for MEDLINE]
    6.

    Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells.

    Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR.

    Carcinogenesis. 1998 Feb;19(2):291-8.

    PMID:
    9498279
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.

    Chang TK, Chen J, Yang G, Yeung EY.

    J Pineal Res. 2010 Jan;48(1):55-64. Epub 2009 Nov 16.

    PMID:
    19919601
    [PubMed - indexed for MEDLINE]
    8.

    Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.

    Loaiza-Pérez AI, Kenney S, Boswell J, Hollingshead M, Alley MC, Hose C, Ciolino HP, Yeh GC, Trepel JB, Vistica DT, Sausville EA.

    Mol Cancer Ther. 2004 Jun;3(6):715-25.

    PMID:
    15210858
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Bioactivation of the phytoestrogen diosmetin by CYP1 cytochromes P450.

    Androutsopoulos V, Wilsher N, Arroo RR, Potter GA.

    Cancer Lett. 2009 Feb 8;274(1):54-60. Epub 2008 Oct 30.

    PMID:
    18976853
    [PubMed - indexed for MEDLINE]
    10.

    Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells.

    Brantley E, Trapani V, Alley MC, Hose CD, Bradshaw TD, Stevens MF, Sausville EA, Stinson SF.

    Drug Metab Dispos. 2004 Dec;32(12):1392-401. Epub 2004 Sep 8.

    PMID:
    15355884
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines.

    van Duursen MB, Sanderson JT, van der Bruggen M, van der Linden J, van den Berg M.

    Toxicol Appl Pharmacol. 2003 Aug 1;190(3):241-50.

    PMID:
    12902195
    [PubMed - indexed for MEDLINE]
    12.

    Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.

    Döhr O, Vogel C, Abel J.

    Arch Biochem Biophys. 1995 Aug 20;321(2):405-12.

    PMID:
    7646066
    [PubMed - indexed for MEDLINE]
    13.

    Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.

    Iwanari M, Nakajima M, Kizu R, Hayakawa K, Yokoi T.

    Arch Toxicol. 2002 Jun;76(5-6):287-98. Epub 2002 Apr 10.

    PMID:
    12107646
    [PubMed - indexed for MEDLINE]
    14.

    The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.

    Pledgie-Tracy A, Billam M, Hacker A, Sobolewski MD, Woster PM, Zhang Z, Casero RA, Davidson NE.

    Cancer Chemother Pharmacol. 2010 May;65(6):1067-81. Epub 2009 Aug 30.

    PMID:
    19727732
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.

    Sparfel L, Van Grevenynghe J, Le Vee M, Aninat C, Fardel O.

    Carcinogenesis. 2006 Mar;27(3):656-63. Epub 2005 Oct 29.

    PMID:
    16258175
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.

    Chua MS, Kashiyama E, Bradshaw TD, Stinson SF, Brantley E, Sausville EA, Stevens MF.

    Cancer Res. 2000 Sep 15;60(18):5196-203.

    PMID:
    11016648
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.

    Noratto G, Porter W, Byrne D, Cisneros-Zevallos L.

    J Agric Food Chem. 2009 Jun 24;57(12):5219-26.

    PMID:
    19530711
    [PubMed - indexed for MEDLINE]
    19.

    Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.

    Endo K, Uno S, Seki T, Ariga T, Kusumi Y, Mitsumata M, Yamada S, Makishima M.

    Toxicol Appl Pharmacol. 2008 Jul 15;230(2):135-43. Epub 2008 Feb 21.

    PMID:
    18372000
    [PubMed - indexed for MEDLINE]
    20.

    Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.

    Yin F, Giuliano AE, Law RE, Van Herle AJ.

    Anticancer Res. 2001 Jan-Feb;21(1A):413-20.

    PMID:
    11299771
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk